Navigation Links
Biopure Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
Date:7/16/2009

CAMBRIDGE, Mass., July 16 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced today that it has filed a voluntary petition for relief under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Massachusetts. Biopure will continue to manage and operate its businesses and assets during the pendency of the bankruptcy case, subject to the supervision of the Bankruptcy Court.

In connection with the filing Biopure entered into an agreement with OPK Biotech LLC for the sale of substantially all of its assets. The sale is subject to customary closing conditions, approval of the Bankruptcy Court and the conduct of a Bankruptcy Court supervised auction process in which Biopure will seek competing bids to achieve the highest price possible for its assets.

If the proposed OPK Biotech LLC transaction closes, Biopure expects that there will be limited, if any, value for the common stockholders in the bankruptcy liquidation process. Stockholders of a company in Chapter 11 generally receive value only if all claims of the company's secured and unsecured creditors are fully satisfied. Biopure expects such claims will be largely satisfied if the proposed OPK Biotech LLC transaction closes on the contemplated schedule.

Biopure Corporation

Biopure Corporation develops and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues.

    Contact:  Zaf Zafirelis
    Biopure Corporation
    (617) 234-6500
    IR@biopure.com


'/>"/>
SOURCE Biopure Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Biopure Receives Notice of Nasdaq Delisting
2. Biopure Receives Notices About Nasdaq Listing Compliance
3. Biopure Exploring Strategic Options
4. Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
5. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
6. Biopure Sues National Institutes of Health Official
7. Agency Takes Adverse Decision to Biopures Product Registration in South Africa
8. Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
9. Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
10. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
11. Biopure Announces 2007 Fourth Quarter and Year-End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... ... of a new healthcare contact center in Georgia, PENETRON Specialty Products (PSP) provided ... nation’s largest healthcare systems recently invested $51 million to purchase and renovate the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Stem ... recent years. The technology is so cutting edge, in fact, the U.S. Food ... stem cell procedures. However, successful patient outcomes in certain clinical stem cell procedures ...
(Date:2/22/2017)... ... 2017 , ... The National Academy of Certified Care Managers ... 2017 testing period. NACCM, a nonprofit organization, has provided the premier certification for ... periodically re-calibrated to ensure that newly certified professionals are prepared to work effectively ...
(Date:2/22/2017)... TX (PRWEB) , ... February ... ... Risk Adjustment solution leverages advanced data analytics to accurately understand each Medicare ... proper reimbursement for a given population. This new solution helps transform the ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its steady expansion ... H. Rauchman, practicing at North Valley Eye Medical Group in Mission Hills . ... and other personal injury cases. These injuries have a major impact on the ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Spheryx, Inc. ... poster presentation at PittCon 2017 Conference and ... is the world,s largest annual premier conference ... a wide array of industry, academic and ... and QA, food safety, environmental, bioterrorism and ...
(Date:2/23/2017)... Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( www.provectusbio.com ... dermatology biopharmaceutical company, today announced that it has appointed ... as special advisers to the Company,s Board of Directors.  ... on financial and corporate strategy. Provectus also ... up to $2.5 million from Eric Wachter , ...
(Date:2/23/2017)... DEERFIELD, Ill. , Feb. 23, 2017 /PRNewswire/ ... a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) ... Cognition Holdings PLC and Ctrl Group Limited, announced a ... app on an Apple Watch wearable to monitor and ... (MDD). Depression (MDD) is the leading cause ...
Breaking Medicine Technology: